Home Amines 1015787-98-0
1015787-98-0,MFCD24539325
Catalog No.:AA0004RL
1015787-98-0 | Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-
Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
99%
1 week  
$225.00   $158.00
- +
10mg
99%
1 week  
$304.00   $213.00
- +
25mg
99%
1 week  
$558.00   $391.00
- +
50mg
99%
1 week  
$876.00   $613.00
- +
100mg
99%
1 week  
$1,400.00   $980.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Q & A
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA0004RL
Chemical Name:
Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-
CAS Number:
1015787-98-0
Molecular Formula:
C14H19N5O4S
Molecular Weight:
353.3968
MDL Number:
MFCD24539325
IUPAC Name:
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide
InChI:
InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19)
InChI Key:
HLWURFKMDLAKOD-UHFFFAOYSA-N
SMILES:
COc1cc(C(C)C)c(cc1S(=O)(=O)N)Oc1cnc(nc1N)N
UNII:
6K6L7E3F1L
Properties
Computed Properties
 
Complexity:
512  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
353.116g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
353.397g/mol
Monoisotopic Mass:
353.116g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
165A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.7  

Synonyms
 
AF-219 
Gefapixant 
Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)- 
Gefapixant [USAN] 
GTPL9540 
SCHEMBL1493905 
CHEMBL3716057 
HLWURFKMDLAKOD-UHFFFAOYSA-N 
AF219 
BCP26079 
ZINC116342482 
RG-1646 
AF-219 
AF-219; MK-7264 
Ro-4926219 
HY-101588 
RO4926219 
CS-0021727 
RO 4926219 
J3.556.891C 
R-1646 
2-Methoxy-4-isopropyl-5-(2,4-diamino-5-pyrimidinyloxy)benzenesulfonamide 
5-((2,4-diaminopyrimidin-5-yl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide 
1015787-98-0 
5-(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonamide 
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide 
5-((2,4-Diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzenesulfonamide 
5-[(2,4-diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide 
AF9 
MK-7264 
UNII-6K6L7E3F1L 
6K6L7E3F1L 
C14H19N5O4S 
5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide 
Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)- 
Literature

Title: Medicinal chemistry of adenosine, P2Y and P2X receptors.

Journal: Neuropharmacology 20160501

Title: P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

Journal: Lancet (London, England) 20150328

Title: Potential for developing purinergic drugs for gastrointestinal diseases.

Journal: Inflammatory bowel diseases 20140701

Title: The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders.

Journal: Frontiers in cellular neuroscience 20130101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info:
Q & A
Related Products